At the completion of this activity, the participant will be able to:

  1. Discuss the current treatment recommendations for type 1 diabetes management
  2. Recognize the benefits of SGLT2 inhibitors and GLP-1 agonists in patients with T1DM
  3. Review the available literature regarding SGLT2 and GLP-1s in patients with T1DM
  4. Summarize the safety concerns of SGLT2 and GLP-1s in patients with T1DM
Session date: 
11/01/2024 - 12:00pm to 1:00pm EDT
Location: 
AGH Magovern Auditorium and Zoom Webinar
To Join the Zoom Webinar:
https://highmarkhealth.zoom.us/j/98672570454?pwd=VU80YWJYNjgraGVsQ0xkU2xSNWozQT09
Meeting ID: 986 7257 0454; Passcode: 877628
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Please login or register to take this course.